Navigation Links
No link found between soy food and endometrial cancer risk, say researchers
Date:6/17/2014

Researchers have found no evidence of a protective association between soy food and endometrial cancer risk, says a new study published (18 June) in BJOG: An International Journal of Obstetrics and Gynaecology.

Soy foods are an almost exclusive dietary source of isoflavones, a plant-derived estrogen. Some studies have highlighted their potential cancer protective properties, however, research looking at the link to endometrial cancer has been inconsistent.

The study defined short IPI as time from the immediate preceding birth to subsequent birth of the index pregnancy of <6 months, 6 to <12 months, and 12 to <18 months. Researchers categorized the women with short IPIs into two groups, IPI less than 12 months and IPI 12-18 months, comparing them to women who were considered to have an optimal IPI of 18 months or more.

The food questionnaire specifically asked about the consumption of 8 soy food items such as miso soup, tofu and soymilk. Researchers then looked at the total dietary intake of genistein and daidzein, different types of isoflavones.

The women were divided into three groups according to the intake of soy foods and isoflavones. In the follow up, 112 women were diagnosed with endometrial cancer.

Women consuming more isoflavones were older, less likely to be current smokers, alcohol and regular coffee drinkers, and more likely to have a history of diabetes. They also had a higher dietary intake of fruit and vegetables.

Looking specifically at tofu, miso soup and soy food, the researchers found no association with endometrial cancer. Neither higher consumption of total soy foods nor isoflavones were associated with the risk of endometrial cancer after adjustment for factors such as age, alcohol consumption, smoking, BMI, menopausal status, coffee intake and number of deliveries.

Dr Motoki Iwasaki, Epidemiology Division, Epidemiology and Prevention Group, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan and co-author said:

"Our study found that intake of soy and isoflavones were not associated with the risk of endometrial cancer.

"Although the incidence of endometrial cancer is much lower in Asian countries, the incidence rate has been increasing. We also know that the consumption of soy foods among Japanese people is very high.

"We need further studies with a greater number of cases to verify these findings and add to the research base."

John Thorp, BJOG Deputy-Editor-in-Chief, said:

"This large population-based study found no evidence of a protective association of soy food or isoflavone intake and previous studies have been inconsistent.

"Confirmation of these results needs further investigation and larger more diverse studies."


'/>"/>

Contact: Nicole Weingartner
sciencenewsroom@wiley.com
201-748-5808
Wiley
Source:Eurekalert

Related biology news :

1. INRS pays tribute to founding chair of Science and Technology in Society forum
2. Structural Genomics Consortium and CHDI Foundation announce new partnership
3. Stem cells found to play restorative role when affecting brain signaling process
4. Global health grant from the Bill & Melinda Gates Foundation awarded to the University of Surrey
5. Wyss Institute founding director Don Ingber to deliver 2014 Graeme Clark Oration
6. Cats found to eat more in the winter
7. Gene mutation found for aggressive form of pancreatic cancer
8. Newly found dinosaur is long-nosed cousin of Tyrannosaurus rex
9. Distinct avian influenza viruses found in Antarctic penguins
10. Function found for mysterious heart disease gene
11. Counterfeit contraceptives found in South America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... , March 29, 2017  higi, the health IT ... North America , today announced a ... the acquisition of EveryMove. The new investment and acquisition ... of tools to transform population health activities through the ... data. higi collects and secures data today ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the ... won a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to ... Experience from US2020. , US2020’s mission is to change the trajectory of STEM ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology: